Andrew I. Koven
2015
In 2015, Andrew I. Koven earned a total compensation of $12M as President and Chief Business Officer at Aralez Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $196,875 |
|---|---|
| Salary | $264,383 |
| Stock Awards | $11,281,789 |
| Other | $221,919 |
| Total | $11,964,966 |
Koven received $11.3M in stock awards, accounting for 94% of the total pay in 2015.
Koven also received $196.9K in non-equity incentive plan, $264.4K in salary and $221.9K in other compensation.
Rankings
In 2015, Andrew I. Koven's compensation ranked 363rd out of 13,638 executives tracked by ExecPay. In other words, Koven earned more than 97.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 363 out of 13,638 | 97th |
Division Manufacturing | 123 out of 5,187 | 98th |
Major group Chemicals And Allied Products | 52 out of 1,857 | 97th |
Industry group Drugs | 43 out of 1,531 | 97th |
Industry Pharmaceutical Preparations | 36 out of 1,179 | 97th |
Source: SEC filing on March 23, 2017.
Koven's colleagues
We found three more compensation records of executives who worked with Andrew I. Koven at Aralez Pharmaceuticals in 2015.